Skip to content
Open access

An effective method based on targeted deep sequencing to simultaneously estimate mosaic loss of Y chromosome and CHIP-related mutations

Oct 2026 · European Journal of Medical Research · 0 citations

TL;DR

This strategy enables simultaneous detection of mLOY and CHIP mutations, providing a robust tool for investigating CH in age-related disease research and highlighting that targeted deep sequencing is better suited for dissecting the complex interplay of genomic instabilities during aging.

Abstract

Clonal hematopoiesis (CH), prevalent in the elderly, is strongly associated with age-related diseases. Somatic mutations in driver genes and mosaic loss of Y chromosome (mLOY) represent the two major forms of CH in male populations. While capture-based deep sequencing has been widely used for detecting somatic mutations and droplet digital PCR (ddPCR) for mLOY, these methods suffer from limited sensitivity to low-level mLOY and lack the ability to concurrently assess mLOY and point mutations. Here, we present a novel strategy based on targeted deep sequencing to simultaneously estimate mLOY and CHIP-related mutations. First, we validated the reliability of mLOY estimation based on UTY and KDM5D coverage using both whole-genome sequencing and targeted sequencing data. In a cohort of 188 male patients with acute aortic syndrome (AAS), comparative analysis with ddPCR showed that our method exhibited exceptional reliability for detecting high-level mLOY (defined as > 20%), with an AUC of 0.999 (P<0.001). The combined detection of mLOY >20% achieved optimal performance: sensitivity of 87.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 99.4%. Moreover, this strategy has been verified in an independent cohort of 240 male patients with acute coronary syndrome (ACS), which strengthens confidence in the method’s performance across different disease settings. We also explored the association between mLOY and CHIP-related mutations. The results revealed a significant trend: individuals with higher mLOY frequencies were more likely to harbor CHIP mutations. Notably, the co-occurrence of CHIP mutations and mLOY was more pronounced when detected with our method, highlighting that targeted deep sequencing is better suited for dissecting the complex interplay of genomic instabilities during aging. Collectively, this cost-effective strategy enables simultaneous detection of mLOY and CHIP mutations, providing a robust tool for investigating CH in age-related disease research.

Read PDF

Similar papers

Open access Oct 2026

Accurate detection of sub-1% frequency somatic mutations by whole genome sequencing

Mutation detection was degraded in post-mortem samples, and it is shown that combining ~200× coverage across tissues from a donor is a feasible strategy for detecting developmental mutations shared across tissues.

Yeongjun Jang, Stephanie Gardiner, Yifan Wang et al. · 2 citations
Open access Oct 2026

Single-molecule real-time (SMRT) sequencing technology shows advantages in the clinical diagnosis of complex thalassemia

Background Thalassemia is a hereditary hemolytic anemia caused by pathogenic variants in the α- or β-globin genes, resulting in imbalanced globin chain synthesis. Clinical manifestations vary from asymptomatic carrier states to severe transfusion-dependent anemia. Current routine diagnostic methods in China, gap polyme...

Ning Tang, Shi-Qiang Luo, Xing-Yuan Chen et al. · 0 citations
Open access Nov 2026

Diagnostic Value in Discarded Reads: Re-evaluating Multi-Mapping cfDNA Fragmentomics and GC Bias in Early-Stage Cancer.

Background. Low-coverage plasma cell-free DNA (cfDNA) sequencing is an inexpensive substrate for cancer detection. Standard pipelines discard fragments with low mapping quality, which originate mostly from repetitive DNA, although pericentromeric satellite repeats are frequently hypomethylated in cancer. We asked wheth...

N. Kadali, K. Uppaluri, H. J. Challa et al. · 0 citations
Open access Nov 2026

Development of an Amplicon-Based Next-Generation Sequencing Assay for Pan-type Detection of BCR::ABL1 Kinase Domain Mutations.

BCR::ABL1 kinase domain (KD) mutations confer tyrosine kinase inhibitor (TKI) resistance in Philadelphia chromosome-positive (Ph+) leukemia, but conventional Sanger sequencing (SS) has limited sensitivity and most next-generation sequencing (NGS) assays cover only a single transcript type. We developed an amplicon-base...

H. Lee, Taek Gyu Lee, Eunju Yeom et al. · 0 citations
Open access Sep 2026

Leveraging Long-Read Sequencing to Bridge the Diagnostic and Equity Gaps in Differences of Sex Development (DSD).

Congenital Adrenal Hyperplasia (CAH) can result from variants in several genes but is most frequently caused by deletions and gene conversions in the segmentally duplicated RCCX module, which contains the CYP21A2 gene and its pseudogene. Current genetic tests vary greatly by laboratory, method, and consequently diagnos...

Emmanuèle C. Délot, Eric Vilain · 0 citations
Open access Oct 2026

Comprehensive benchmarking of somatic mutation detection by the SMaHT Network.

Somatic mosaicism is increasingly recognized as a fundamental feature of human biology, yet the detection of somatic mutations remains challenging. The Somatic Mosaicism across Human Tissues (SMaHT) Network conducted large-scale benchmarking experiments involving cell lines and donor tissues to evaluate sequencing tech...

A. Abyzov, Abhiram Natu, Adam Voshall et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.